Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/1999

01-06-1999 | ORIGINAL ARTICLE

Low-energy He/Ne laser in the prevention of radiation-induced mucositis

A multicenter phase III randomized study in patients with head and neck cancer

Authors: R. J. Bensadoun, J. C. Franquin, G. Ciais, V. Darcourt, M. M. Schubert, M. Viot, J. Dejou, C. Tardieu, K. Benezery, T. D. Nguyen, Y. Laudoyer, O. Dassonville, G. Poissonnet, J. Vallicioni, A. Thyss, M. Hamdi, P. Chauvel, F. Demard

Published in: Supportive Care in Cancer | Issue 4/1999

Login to get access
Metadata
Title
Low-energy He/Ne laser in the prevention of radiation-induced mucositis
A multicenter phase III randomized study in patients with head and neck cancer
Authors
R. J. Bensadoun
J. C. Franquin
G. Ciais
V. Darcourt
M. M. Schubert
M. Viot
J. Dejou
C. Tardieu
K. Benezery
T. D. Nguyen
Y. Laudoyer
O. Dassonville
G. Poissonnet
J. Vallicioni
A. Thyss
M. Hamdi
P. Chauvel
F. Demard
Publication date
01-06-1999
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/1999
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200050256

Other articles of this Issue 4/1999

Supportive Care in Cancer 4/1999 Go to the issue

ORIGINAL ARTICLE

Analysis of early infectious complications in pediatric patients undergoing bone marrow transplantation

EDITORIAL

Oral infection

SUPPORTIVE CARE INTERNATIONAL

Palliative care in the University Hospital Lausanne: from consultations to an integrated regional program

OriginalPaper

MEETING HIGHLIGHT

ORIGINAL ARTICLE

The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain

ORIGINAL ARTICLE

Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits